|
|
Article: Autologous Bone Marrow Transplant (BMT) Purged With Anti-CD33 Immunotoxin for Patients with Acute Myeloid Leukemia (AML).
- Article from:
- Immunotherapy Weekly
- Article date:
- April 19, 1999
CopyrightCOPYRIGHT 1999 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bone Marrow Purging
"Autologous Bone Marrow Transplant (BMT) Purged With Anti-CD33 Immunotoxin for Patients with Acute Myeloid Leukemia (AML)." J. Lavoie, R. Belanger, M.J. Robertson, R. Stone, C. Perreault, J. Kassis, L. Busque, R.J. Soiffer, J. Ritz and D.C. Roy. Div. of Hematology-Immunology, Maisonneuve-Rosemont Hospital, Montreal, Canada; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
(CW HENDERSON PUBLISHER www.newsfile.com) -- According to an abstract submitted by the authors to the 40th Annual American Society of Hematology Meeting, held December 4-8, 1998, in Miami Beach, Florida, "Autologous BMT is a ...